Professor John Hardy (MyAV范 Queen Square Institute of Neurology) and Professor Bart De Strooper (UK Dementia Research Institute at MyAV范) reflect on the success of lecanemab trials, the potentially breakthrough Alzheimer's treatment which appears to reduce the disease's progression.
Close
